Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Vila-Castelar, Claraa | Guzmán-Vélez, Edmariea | Pardilla-Delgado, Enmanuellea | Buckley, Rachel F.b | Bocanegra, Yamilec | Baena, Anac | Fox-Fuller, Joshua T.a; d | Tirado, Victoriac | Muñoz, Claudiac | Giraldo, Margaritac | Acosta-Baena, Nataliac | Rios-Romenets, Silviac | Langbaum, Jessica B.e | Tariot, Pierre N.e | Lopera, Franciscoc | Reiman, Eric M.e | Quiroz, Yakeel T.a; b; c; *
Affiliations: [a] Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA | [b] Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA | [c] Grupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellín, Colombia | [d] Department of Psychological & Brain Sciences, Boston University, Boston, MA, USA | [e] Banner Alzheimer’s Institute, Phoenix, AZ, USA
Correspondence: [*] Correspondence to: Yakeel T. Quiroz, Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. E-mail: [email protected].
Abstract: Background:Growing evidence suggests that there may be a sex-specific biological risk for Alzheimer’s disease (AD). Individuals with autosomal dominant AD due to a mutation (E280A) in Presenilin-1 (PSEN1) are genetically determined to develop early-onset dementia and thus, have few age-related risk factors for AD that are known to vary by sex (i.e., cardiovascular disease, menopause, life expectancy). Objective:Investigate sex differences in markers of cognition and neurodegeneration in autosomal dominant AD. Methods:We conducted a retrospective study in 19 cognitively-unimpaired PSEN1 mutation carriers (age range 20–44; 11 females), 11 symptomatic carriers (age range 42–56; 8 females), and 23 matched non-carriers family members (age range 20–50; 13 females). We examined hippocampal volume ratio, CERAD Total Score, and CERAD Word List (i.e., Learning, Delayed Recall, and Recognition). Mann-Whitney U tests, Spearman correlations and regression models were conducted. Results:There were no differential associations between age, CERAD Total Score, CERAD Word List–Learning, Delayed Recall, Recognition, and hippocampal volume ratio in male and female carriers and non-carriers. Cognitively-unimpaired female carriers showed better CERAD Total scores and CERAD Word List-Learning than cognitively-unimpaired male carriers, despite having similar hippocampal volume ratios. The interaction of sex and hippocampal volume ratio did not predict cognitive performance across groups. Conclusion:Our preliminary findings suggest that cognitively-unimpaired female carriers showed a verbal memory reserve, and as disease progresses, female carriers did not exhibit a cognitive susceptibility to AD-related neurodegeneration. Future studies with larger samples of autosomal dominant AD are warranted to further understand sex differences in AD-related clinical and pathological markers.
Keywords: Alzheimer’s disease, atrophy, cognition, familial Alzheimer’s disease, memory, sex
DOI: 10.3233/JAD-200723
Journal: Journal of Alzheimer's Disease, vol. 77, no. 4, pp. 1743-1753, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]